Search Results 231-240 of 7017 for Suvorexant

  1. Cipepofol (intravenous route) - Side effects & uses - Mayo Clinic

    Check with your doctor right away if you have chest tightness, cough, difficulty swallowing, dizziness, hives, itching, skin rash, puffiness or swelling of the ...

  2. Safety And Pharmacology Of SNX-5422 Plus Everolimus In Subjects With Neuroendocrine Tumors - Mayo Clinic

    Study is designed to determine the maximum tolerated dose (MTD) of SNX-5422 when given in combination with everolimus. Participation eligibility. Participant ...

  3. Osteosarcoma - Doctors and departments - Mayo Clinic

    Learn about the symptoms and causes of this bone cancer that happens most often in children. Find out about treatments, including limb-sparing operations.

  4. Sonrotoclax (oral route) - Side effects & dosage - Mayo Clinic

    Sonrotoclax is used to treat mantle cell lymphoma that has come back or did not respond to previous treatment in patients who have received at least 2 cancer ...

  5. Cetrorelix (subcutaneous route) - Mayo Clinic

    GnRH controls another hormone that is called luteinizing hormone (LH), which is the hormone that starts ovulation during the menstrual cycle. When undergoing ...

  6. Vulvar cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.

  7. Vulvar cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.

  8. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    This pilot clinical trial studies how well buparlisib works in treating patients with non-Hodgkin lymphoma that has returned or does not respond to treatment.

  9. Bemarituzumab Plus Chemotherapy And Nivolumab Versus Chemotherapy And Nivolumab Alone - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Study Evaluating The Safety And Effectiveness Of BIV201 And Standard Of Care Compared To Standard Of Care To Reduce The Recurrence Of Ascites And Complications In Patients With Refractory Ascites Secondary To Decompensated Liver Cirrhosis - Mayo Clinic

    The purpose of this study is to evaluate the clinical effectiveness of BIV201 continuous infusion in addition to SOC compared to SOC alone in adult patients ...